Publications

5600 Results

Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812)

Authors
K Crew;G Anderson;D Hershman;M Terry;D Lew;M Yee;EA Brown;S Kairouz;L Minasian;L Ford;B Arun;M Neuhouser;P Brown
Journal / Conference
San Antonio Breast Cancer Symposium (December 5-9, 2017, San Antonio, TX), poster
Year
2017
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0812

SWOG S1418/NRG -BR006: A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with > 1 cm Residual Invasive Cancer or Positive Lymph Nodes (>pN1mic) After Neoadjuvant Chemotherapy

Authors
L Pusztai;W Barlow;P Ganz;NL Henry;J White;R Jagsi;J Mammen;D Lew;J Mejia;V Karantza;G Aktan;G Hortobagyi;E Mamounas
Journal / Conference
San Antonio Breast Cancer Symposium (December 5-9, 2017, San Antonio, TX), poster
Year
2017
Research Committee(s)
Breast

Progress in lung squamous cell carcinoma from the Lung-MAP master protocol (S1400) sub-studies S1400A, S1400B, S1400C and S1400D

Authors
R Herbst;M Redman;D Gandara;F Hirsch;PC Mack;H Borghaei;C Langer;JL Wade;J Engelman;M Edelman;KS Albain;P Lara;C Aggarwal;M Socinski;S Gettinger;L Bazhenova;S Waqar;F Robert;G Kiefer;JD Bradley;J Crawford;E McGary;N Rafique;D Petro;PC Hoffman;Y Zhou;J Miao;K Griffin;S McDonough;C Miwa;S Malik;VA Miller;EV Sigal;S Adam;CD Blanke;K Kelly;V Papadimitrakopoulou
Journal / Conference
IASLC World Conference on Lung Cancer (October 15 - 18 2017, Yokohama, Japan), abst. OA 14.07, oral presentation
Year
2017
Research Committee(s)
Lung
Study Number(s)
S1400, S1400A, S1400B, S1400C, S1400D

Longitudinal analysis of plasma ctDNA in EGFR-mutant NSCLC: SWOG S1403 trial of afatinib with or without cetuximab

Authors
P Mack;J Miao;KC Banks;R Burich;K Politi;V Raymond;D Dix;R Lanman;J Moon;M Redman;S Goldberg;D Gandara;K Kelly
Journal / Conference
IASLC World Conference on Lung Cancer (October 15 - 18 2017, Yokohama, Japan), poster presentation, abst. P3.01-046
Year
2017
Research Committee(s)
Lung
Study Number(s)
S1403

A Clinical Prognostic Model for Survival of Elderly Patients with Non-Small Cell Lung Cancer

Authors
AK Ganti;X Wang;TE Stinchcombe;YA Wang;K Kelly;R Paulus;JD Bradley;S Ramalingam;H Cohen;E Vokes;H Pang
Journal / Conference
IASLC World Conference on Lung Cancer (October 15 - 18 2017, Yokohama, Japan), accepted, oral
Year
2017
Research Committee(s)
Lung
Study Number(s)
S0339, S0342, SWOG-9308, SWOG-9509, S9806

Effects of metformin versus placebo on vitamin B12 metabolism in non-diabetic breast cancer patients in CCTG MA.32

Authors
AE Lohmann;MF Liebman;W Brien;WR Parulekar;KA Gelmon;LE Shepherd;J Ligibel;DL Hershman;P Rastogi;IA Mayer;TJ Hobday;J Lemieux;AM Thompson;KI Pritchard;TJ Whelan;S Mukherjee;HI Chalchal;V Bernstein;V Stambolic;BE Chen;PJ Goodwin
Journal / Conference
Breast Cancer Research and Treatment Jul;164(2):371-378
Year
2017
Research Committee(s)
Breast
PMID
PMID28447237
PMC
PMC5798974

Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adj) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): The IDEA (International Duration Evaluation of Adjuvant chemotherapy) collaboration

Authors
A Grothey;AF Sobrero;JA Meyerhardt;T Yoshino;J Paul;J Taieb;I Soougklakos;R Kerr;R Labianca;A Shields;F Bonnetain;T Yamanaka;I Boukovinas;Q Shi;JP Meyers;D Niedzwiecki;V Torri;DJ Sargent;T Andre;T Iveson
Journal / Conference
European Society of Medical Oncology (ESMO) 2017 (September 8-12, 2017, Madrid, Spain), poster
Year
2017
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80702

Exome Sequencing of Tumor Tissue Samples Collected from Patients Participating in SWOG S1107 “Parallel (Randomized) Phase II Evaluation of Tivantinib (ARQ-197) and Tivantinib in Combination with Erlotinib in Papillary Renal Cell carcinoma (pRCC)

Authors
P Twardowski;X Wu;CM Tangen;E Plimack;N Agarwal;M Plets;N Vogelzang;J Wang;S Tao;IM Thompson;PN Lara
Journal / Conference
Annals of Oncology Sep; 28:Supplement abst. 910P, p.323; ESMO Annual Meeting (September 8-12, 2017, Madrid, Spain), poster
Year
2017
Research Committee(s)
Genitourinary
Study Number(s)
S1107

Genomic Alterations Important for the Prognosis in Patients with Follicular Lymphoma Treated on SWOG Study S0016

Authors
X Qu;H Li;O Press;L Rimsza;R Braziel;M LeBlanc;E Hsi;JP Leonard;S Smith;JW Friedberg;M Fang
Journal / Conference
American Society of Hematology Annual Meeting (December 9-12, 2017, Atlanta, GA), poster
Year
2017
Research Committee(s)
Lymphoma
Study Number(s)
S0016

Serum levels of TARC, MDC, IL10 and soluble CD163 in the setting of risk adapted therapy for Hodgkin lymphoma: SWOG S0816 correlative study

Authors
E Hsi;H Li;AB Nixon;AM Evens;H Schoder;D Straus;N Bartlett;J Sweetenham;PM Barr;MA Fanale;JR Cook;BS Kahl;JP Leonard;S Smith;M LeBlanc;LM Rimsza;JW Friedberg;OW Press
Journal / Conference
Blood 130:4033; American Society of Hematology Annual Meeting (December 9-12, 2017, Atlanta, GA), poster
Year
2017
Research Committee(s)
Lymphoma
Study Number(s)
S0816